Trial Profile
A Study to Evaluate the Potential Drug-Drug Interaction Between Danoprevir When Coadministered With Low-Dose Ritonavir and Tenofovir Disoproxil Fumarate or Atazanavir in Healthy Adult Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 Jun 2016
Price :
$35
*
At a glance
- Drugs Danoprevir (Primary) ; Atazanavir; Ritonavir; Tenofovir disoproxil fumarate
- Indications Hepatitis B; Hepatitis C; HIV-1 infections; HIV-2 infections
- Focus Pharmacokinetics
- Sponsors Roche
- 01 Aug 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 21 May 2012 Planned End Date changed from 1 Sep 2012 to 1 Jul 2012 as reported by ClinicalTrials.gov.
- 21 May 2012 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.